Zúñiga Ana, Muñoz-Guamuro Geisler, Boivineau Lucile, Mayonove Pauline, Conejero Ismael, Pageaux Georges-Philippe, Altwegg Romain, Bonnet Jerome
Centre de Biologie Structurale (CBS), INSERM U1054, CNRS UMR5048, University of Montpellier, Montpellier, France.
Hepatogastroenterology and Bacteriology Service at CHU Montpellier, University of Montpellier, Montpellier, France.
Front Bioeng Biotechnol. 2022 Aug 22;10:859600. doi: 10.3389/fbioe.2022.859600. eCollection 2022.
Gut metabolites are pivotal mediators of host-microbiome interactions and provide an important window on human physiology and disease. However, current methods to monitor gut metabolites rely on heavy and expensive technologies such as liquid chromatography-mass spectrometry (LC-MS). In that context, robust, fast, field-deployable, and cost-effective strategies for monitoring fecal metabolites would support large-scale functional studies and routine monitoring of metabolites biomarkers associated with pathological conditions. Living cells are an attractive option to engineer biosensors due to their ability to detect and process many environmental signals and their self-replicating nature. Here we optimized a workflow for feces processing that supports metabolite detection using bacterial biosensors. We show that simple centrifugation and filtration steps remove host microbes and support reproducible preparation of a physiological-derived media retaining important characteristics of human feces, such as matrix effects and endogenous metabolites. We measure the performance of bacterial biosensors for benzoate, lactate, anhydrotetracycline, and bile acids, and find that they are highly sensitive to fecal matrices. However, encapsulating the bacteria in hydrogel helps reduce this inhibitory effect. Sensitivity to matrix effects is biosensor-dependent but also varies between individuals, highlighting the need for case-by-case optimization for biosensors' operation in feces. Finally, by detecting endogenous bile acids, we demonstrate that bacterial biosensors could be used for future metabolite monitoring in feces. This work lays the foundation for the optimization and use of bacterial biosensors for fecal metabolites monitoring. In the future, our method could also allow rapid pre-prototyping of engineered bacteria designed to operate in the gut, with applications to diagnostics and therapeutics.
肠道代谢物是宿主与微生物群相互作用的关键介质,为了解人类生理和疾病提供了重要窗口。然而,目前监测肠道代谢物的方法依赖于液相色谱 - 质谱联用(LC-MS)等笨重且昂贵的技术。在这种情况下,用于监测粪便代谢物的强大、快速、可现场部署且具有成本效益的策略将有助于大规模功能研究以及对与病理状况相关的代谢物生物标志物进行常规监测。活细胞因其能够检测和处理多种环境信号以及自我复制的特性,是构建生物传感器的一个有吸引力的选择。在这里,我们优化了粪便处理流程,以支持使用细菌生物传感器检测代谢物。我们表明,简单的离心和过滤步骤可去除宿主微生物,并支持可重复制备保留人类粪便重要特征(如基质效应和内源性代谢物)的生理衍生培养基。我们测量了细菌生物传感器对苯甲酸盐、乳酸盐、脱水四环素和胆汁酸的性能,发现它们对粪便基质高度敏感。然而,将细菌封装在水凝胶中有助于降低这种抑制作用。对基质效应的敏感性因生物传感器而异,且在个体之间也有所不同,这突出了针对生物传感器在粪便中的操作进行逐案优化的必要性。最后,通过检测内源性胆汁酸,我们证明细菌生物传感器可用于未来粪便中的代谢物监测。这项工作为优化和使用细菌生物传感器进行粪便代谢物监测奠定了基础。未来,我们的方法还可实现旨在在肠道中运行的工程细菌的快速原型制作,应用于诊断和治疗。